BR9912062A - Compostos orgânicos fosforosos e seu uso - Google Patents

Compostos orgânicos fosforosos e seu uso

Info

Publication number
BR9912062A
BR9912062A BR9912062-3A BR9912062A BR9912062A BR 9912062 A BR9912062 A BR 9912062A BR 9912062 A BR9912062 A BR 9912062A BR 9912062 A BR9912062 A BR 9912062A
Authority
BR
Brazil
Prior art keywords
organic compounds
formula
phosphorous organic
compounds
bactericide
Prior art date
Application number
BR9912062-3A
Other languages
English (en)
Inventor
Hassan Jomaa
Original Assignee
Hassan Jomaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19831639A external-priority patent/DE19831639C1/de
Priority claimed from DE19843360A external-priority patent/DE19843360A1/de
Application filed by Hassan Jomaa filed Critical Hassan Jomaa
Publication of BR9912062A publication Critical patent/BR9912062A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/383—Cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Agronomy & Crop Science (AREA)
  • Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)

Abstract

Patente de Invenção: <B>"COMPOSTOS ORGâNICOS FOSFOROSOS E SEU USO"<D>. Uso de compostos orgânicos fosforosos de fórmula geral (I) em que B representa ou um grupo éter de fórmula (II) ou um grupo ceto de fórmula (III) ou é um composto cíclico com 5 ou 6 elementos, e seu uso para preparar composições farmacêuticas durante o tratamento terapêutico e profiláctico de infecções em seres seres humanos e animais devido aos vírus, bactérias, fungos, e parasitas assim como seu uso como fungicida, bactericida e herbicida em plantas.
BR9912062-3A 1998-07-15 1999-07-09 Compostos orgânicos fosforosos e seu uso BR9912062A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19831639A DE19831639C1 (de) 1998-07-15 1998-07-15 Phosphororganische Verbindungen und ihre Verwendung
DE19843360A DE19843360A1 (de) 1998-09-22 1998-09-22 Phosphororganische Verbindungen und ihre Verwendung
PCT/EP1999/004827 WO2000004031A1 (de) 1998-07-15 1999-07-09 Phosphororganische verbindungen und ihre verwendung

Publications (1)

Publication Number Publication Date
BR9912062A true BR9912062A (pt) 2001-04-03

Family

ID=26047426

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9912062-3A BR9912062A (pt) 1998-07-15 1999-07-09 Compostos orgânicos fosforosos e seu uso

Country Status (22)

Country Link
US (2) US6812224B2 (pt)
EP (1) EP1095050A1 (pt)
JP (1) JP2002520419A (pt)
KR (1) KR20010070962A (pt)
CN (1) CN1309659A (pt)
AP (1) AP2001002051A0 (pt)
AU (1) AU754165B2 (pt)
BR (1) BR9912062A (pt)
CA (1) CA2336143A1 (pt)
EA (1) EA200100143A1 (pt)
EE (1) EE200100027A (pt)
HR (1) HRP20010035A2 (pt)
HU (1) HUP0103481A3 (pt)
ID (1) ID27347A (pt)
IL (1) IL140433A0 (pt)
IS (1) IS5784A (pt)
NO (1) NO20010200L (pt)
PL (1) PL345864A1 (pt)
SK (1) SK662001A3 (pt)
TR (1) TR200100068T2 (pt)
WO (1) WO2000004031A1 (pt)
YU (1) YU2201A (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200100068T2 (tr) * 1998-07-15 2001-06-21 Jomaa,Hassan Fosforlu organik bileşikler ve kullanımları
JP2004508283A (ja) * 2000-02-18 2004-03-18 ヨマー、ファルマカ、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング 有機リン化合物およびその使用
DE10014127A1 (de) * 2000-03-22 2001-10-18 Hassan Jomaa Verwendung von phosphororganischen Verbindungen zur Behandlung von Infektionen
DE10127936A1 (de) * 2000-06-08 2001-12-13 Jomaa Pharmaka Gmbh Phosphororganische Hydroxamsäurederivate als Herbizide
WO2001093872A1 (de) * 2000-06-08 2001-12-13 Jomaa Pharmaka Gmbh Verwendung von phosphororganischen hydroxamsäurederivaten zur herstellung von arzneimitteln
WO2002078714A1 (de) * 2001-03-30 2002-10-10 Jomaa Pharmaka Gmbh Magensaftresistente formulierungen zur applikation von antiinfektiös wirkenden verbindungen, die den 2-c-methylerythrose-4-stoffwechselweg hemmen, sowie ihren salzen und estern
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
MXPA03006549A (es) * 2003-07-22 2004-03-18 Univ Autonoma Metropolitana Uso de la dapsona como neuroprotector en el infarto cerebral.
US7122700B2 (en) 2004-07-30 2006-10-17 Xerox Corporation Arylamine processes
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
WO2010019511A2 (en) * 2008-08-13 2010-02-18 Targanta Therapeutics Corp. Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
EP2725029A1 (en) * 2012-10-29 2014-04-30 Laboratoire Biodim New antibacterial compounds and biological applications thereof
CN105319355A (zh) * 2014-07-25 2016-02-10 江苏维赛科技生物发展有限公司 敌百虫胶体金试纸条的制备及使用方法
MX2017003251A (es) 2014-09-12 2017-12-20 Antibiotx Aps Uso antibacteriano de salicilanilidas halogenadas.
US9974800B2 (en) 2014-10-24 2018-05-22 Redhill Biopharma Ltd. Therapy for inhibition of single-stranded RNA virus replication
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH433290A (de) * 1963-05-13 1967-04-15 Monsanto Co Verfahren zur Herstellung von Diorganohalogenphosphinen
US4038311A (en) * 1969-01-14 1977-07-26 Basf Aktiengesellschaft Production of n-(1-alkenyl)-carbamyl chlorides
DE2032712C3 (de) * 1970-07-02 1978-10-19 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von w-Amino-alkanphosphonsäure bzw.- phosphinsäurederivaten
GB1580899A (en) * 1976-07-27 1980-12-10 Fujisawa Pharmaceutical Co Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof
US4087522A (en) 1976-09-08 1978-05-02 Abbott Laboratories Amides of phosphonoacetic acid for treating herpes simplex virus type 1 and 2 infections
US4268503A (en) * 1978-09-14 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
DE3026326A1 (de) 1980-07-11 1982-02-11 Bayer Ag, 5090 Leverkusen N-phosphonylcarbonyl-carbamate, verfahren zu ihrer herstellung, diese verbindungen enthaltende schaedlingsbekaempfungsmittel und ihre verwendung zur schaedlingsbekaempfung
US4579691A (en) * 1983-04-21 1986-04-01 Ciba-Geigy Corporation Haloacylaminoalkylphosphonates
US4693742A (en) * 1983-12-20 1987-09-15 Rohm And Hass Company Herbicidal hydroxyamino phosphonic acids and derivatives
US4646298A (en) * 1984-05-01 1987-02-24 Texas Instruments Incorporated Self testing data processing system with system test master arbitration
JPS61106504A (ja) * 1984-10-30 1986-05-24 Teijin Ltd 除草剤
US4679691A (en) * 1985-08-12 1987-07-14 Halloran Kevin J Three-sided tip tray
GB8911017D0 (en) 1989-05-13 1989-06-28 Ciba Geigy Ag Substituted aminoalkylphosphinic acids
GB8912814D0 (en) 1989-06-03 1989-07-19 Ciba Geigy Ag P-substituted propane-phospinic acid compounds
SK282950B6 (sk) 1990-04-24 2003-01-09 Biota Scientific Management Pty Ltd Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze
DE4028046A1 (de) 1990-09-05 1992-03-12 Bayer Ag Arzneimittel enthaltend substituierte 2-cyclohexen-1-yl-amin-derivate und ihre verwendung zur bekaempfung von krankheiten
DK0923585T3 (da) 1996-07-18 2002-07-01 Pfizer Phosphinatbaserede inhibitorer af matrixmetalloproteinaser
TR200100068T2 (tr) * 1998-07-15 2001-06-21 Jomaa,Hassan Fosforlu organik bileşikler ve kullanımları
US6753324B2 (en) * 1998-07-15 2004-06-22 Hassan Jomaa Phosphorous organic compounds and their use

Also Published As

Publication number Publication date
AU5158099A (en) 2000-02-07
HUP0103481A2 (en) 2002-06-29
PL345864A1 (en) 2002-01-14
AP2001002051A0 (en) 2001-03-31
IL140433A0 (en) 2002-02-10
ID27347A (id) 2001-04-05
CN1309659A (zh) 2001-08-22
WO2000004031A1 (de) 2000-01-27
US20050075511A1 (en) 2005-04-07
EA200100143A1 (ru) 2001-06-25
HRP20010035A2 (en) 2001-12-31
KR20010070962A (ko) 2001-07-28
US20030045746A1 (en) 2003-03-06
AU754165B2 (en) 2002-11-07
US6812224B2 (en) 2004-11-02
SK662001A3 (en) 2001-10-08
NO20010200L (no) 2001-03-14
HUP0103481A3 (en) 2003-01-28
TR200100068T2 (tr) 2001-06-21
YU2201A (sh) 2003-01-31
CA2336143A1 (en) 2000-01-27
EP1095050A1 (de) 2001-05-02
JP2002520419A (ja) 2002-07-09
EE200100027A (et) 2002-06-17
IS5784A (is) 2000-12-21
NO20010200D0 (no) 2001-01-12

Similar Documents

Publication Publication Date Title
BR9912062A (pt) Compostos orgânicos fosforosos e seu uso
BR9814636A (pt) &#34;isotiazolcarboxamidas&#34;
BR9909668A (pt) Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções
BR0214736A (pt) Composto e seus sais farmaceuticamente aceitáveis, composição farmacêutica e método de tratar seres humanos ou animais que sofrem de doenças ou condições
BR9813536A (pt) &#34;derivados oxima e produtos quìmicos agrìcolas incluindo os mesmos&#34;
DE69931809D1 (de) Antibakterielle protonierte oligonukleotide
BR0111914A (pt) Composições endoparasiticidas para absorção oral voluntária pelos animais
BR0015909A (pt) N-heteroaril alfa-alcoximino-carboxamidas pesticidas
WO2000044359A3 (de) Verwendung von thiadiazolderivaten zur prophylaktischen und therapeutischen behandlung von infektionen
BR0209430A (pt) Compostos heterocìclicos
BR9915639A (pt) Uso de derivados de ácido fosfonofórmico para o tratamento de infecções
BR9913990A (pt) Uso de compostos organofosforados para a produção de preparações farmacêuticas para o tratamento terapêutico e profilático de infecções ou como um fungicida, bactericida ou herbicida em plantas
BR9916850A (pt) Uso de bisfosfonatos para a profilaxia e tratamento de processos infecciosos
BR0206310A (pt) Composição agrìcola e hortìcola, composição microbicida para agricultura e horticultura, e, métodos para reforçar o efeito microbicida de um composto e seus sais, e para reforçar o efeito microbicida ou o efeito inseticida de um ingrediente ativo quìmico agrìcola diferente ou seus sais
BR9916466A (pt) Compostos de organofósforo e seu uso
BR0015722A (pt) Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas
BR9915671A (pt) Compostos de organofósforo e uso dos mesmos
WO2000044358A3 (de) Verwendung von phosphororganischen verbindungen zur prophylaktischen und therapeutischen behandlung von infektionen
BR9915605A (pt) Uso de derivados do ácido fosfonofórmico para o tratamento de infecções
BR0013085A (pt) Compostos espiro heterocìclicos como pesticidas
DK0505389T3 (da) Antiparasitisk præparat til animalsk anvendelse
BR0007491A (pt) Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções
DE50104130D1 (de) Anthelminthika zur verhinderung von parasitären infektionen bei mensch und tier iii
BR0016427A (pt) Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica
EA200001065A1 (ru) Применение фосфорорганических соединений для терапевтического и профилактического лечения инфекций

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.